Morrison Scott W — SEC Form 4 filings

SEC reporting owner CIK 1662426. 20 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2024-05-17 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zai Lab Ltd (ZLAB)Director41 leg · 23,799 sh · $715,0863
Tarsus Pharmaceuticals, Inc. (TARS)Director817
IDEAYA Biosciences, Inc. (IDYA)Director33
Vera Therapeutics, Inc. (VERA)Director33
Corvus Pharmaceuticals, Inc. (CRVS)Director22

Form 4 filings — Morrison Scott W

FiledFormIssuerReported transactionsSource
2026-06-294Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 3,837 (derivative) @ $0 · Grant/award (A): 2,417 (derivative) @ $0EDGAR
2026-06-224Zai Lab Ltd (ZLAB)Grant/award (A): 22,371 @ $0EDGAR
2026-06-184IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-06-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 2,954 · Option exercise (M): 2,954 (derivative) @ $0EDGAR
2026-05-264Vera Therapeutics, Inc. (VERA)Grant/award (A): 17,084 (derivative) @ $0EDGAR
2025-09-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0EDGAR
2025-06-264IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-234Zai Lab Ltd (ZLAB)Grant/award (A): 10,831 @ $0EDGAR
2025-06-164Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 3,350 · Grant/award (A): 4,540 (derivative) @ $0 · Grant/award (A): 2,954 (derivative) @ $0 · Option exercise (M): 3,350 (derivative) @ $0EDGAR
2025-05-164Vera Therapeutics, Inc. (VERA)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2025-05-134Zai Lab Ltd (ZLAB)Sale (S): 23,799 @ $30.05EDGAR
2024-10-024Tarsus Pharmaceuticals, Inc. (TARS)Gift (G): 6,016 @ $0EDGAR
2024-09-174Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 1,333 · Option exercise (M): 1,333 (derivative) @ $0EDGAR
2024-06-254Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 3,350 · Option exercise (M): 3,350 (derivative) @ $0EDGAR
2024-06-204Zai Lab Ltd (ZLAB)Grant/award (A): 21,253 @ $0EDGAR
2024-06-174Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-144Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 3,350 (derivative) @ $0EDGAR
2024-05-314IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 16,200 (derivative) @ $0EDGAR
2024-05-174Vera Therapeutics, Inc. (VERA)Grant/award (A): 14,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662426 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →